pramipexole has been researched along with serine in 2 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (serine) | Trials (serine) | Recent Studies (post-2010) (serine) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 23,914 | 115 | 6,084 |
| Protein | Taxonomy | pramipexole (IC50) | serine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.015 | |
| Cholinesterase | Equus caballus (horse) | 0.016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chau, KY; Cooper, JM; Schapira, AH | 1 |
| Liu, J; Qian, Y; Xiao, Q; Xu, S; Yang, X | 1 |
2 other study(ies) available for pramipexole and serine
| Article | Year |
|---|---|
Pramipexole reduces phosphorylation of α-synuclein at serine-129.
Topics: alpha-Synuclein; Antiparkinson Agents; Benzothiazoles; Casein Kinase II; Cell Line, Tumor; Humans; Phosphorylation; Pramipexole; Serine | 2013 |
Association of the DRD2 CA
Topics: Aged; Aged, 80 and over; Analysis of Variance; Benzothiazoles; Case-Control Studies; Dinucleotide Repeats; Dopamine Agonists; Female; Genotype; Glycine; Humans; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Serine | 2017 |